- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Chengdu Olymvax Biopharmaceuticals Inc (688319)
Chengdu Olymvax Biopharmaceuticals Inc stock price live, this page displays SS 688319 stock exchange data. View the 688319 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Chengdu Olymvax Biopharmaceuticals Inc real time stock price chart below.
What Is the Chengdu Olymvax Biopharmaceuticals Inc Stock Price Today?
The Chengdu Olymvax Biopharmaceuticals Inc stock price today is 17.75.
What Is the Stock Symbol for Chengdu Olymvax Biopharmaceuticals Inc?
The stock symbol for Chengdu Olymvax Biopharmaceuticals Inc is "688319."
What Stock Exchange Does Chengdu Olymvax Biopharmaceuticals Inc Trade On?
Chengdu Olymvax Biopharmaceuticals Inc is listed and trades on the Shanghai stock exchange.
Is Chengdu Olymvax Biopharmaceuticals Inc a Good Stock to Buy?
Determining whether Chengdu Olymvax Biopharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 688319 quote. (ISIN: CNE1000051H8)
What Is the Chengdu Olymvax Biopharmaceuticals Inc Stock Price Today?
The Chengdu Olymvax Biopharmaceuticals Inc stock price today is 17.75.
What Is the Stock Symbol for Chengdu Olymvax Biopharmaceuticals Inc?
The stock symbol for Chengdu Olymvax Biopharmaceuticals Inc is "688319."
What Stock Exchange Does Chengdu Olymvax Biopharmaceuticals Inc Trade On?
Chengdu Olymvax Biopharmaceuticals Inc is listed and trades on the Shanghai stock exchange.
Is Chengdu Olymvax Biopharmaceuticals Inc a Good Stock to Buy?
Determining whether Chengdu Olymvax Biopharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 688319 quote. (ISIN: CNE1000051H8)
Shanghai
Currency in CNY
17.75
+0.25(+1.43%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
17.51
17.85
52 wk Range
8.11
18.74
688319 Scorecard
Full Analysis
Net income is expected to grow this year
688319 is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
17.5117.85
52 wk Range
8.1118.74
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
688319 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
0.00
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Chengdu Olymvax Biopharmaceuticals Company Profile
Chengdu Olymvax Biopharmaceuticals Inc. engages in the research and development, production, and sales of vaccines for human use. It offers adsorbed tetanus vaccine; Hib conjugate vaccine; Group A streptococcus vaccine; and AC conjugate vaccine. The company also provides vaccines for haemophilus influenzae type b; group A and C meningococcal; and staphylococcus aureus, which is in Phase 3 clinical trial. In addition, it engages in technology promotion and application services business; biotechnology, R&D, and consulting. The company was founded in 2009 and is based in Chengdu, China.
Compare 688319 to Peers and Sector
Metrics to compare | 688319 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship688319PeersSector | |
|---|---|---|---|---|
P/E Ratio | 179.7x | −15.3x | −0.5x | |
PEG Ratio | 0.43 | 0.40 | 0.00 | |
Price/Book | 7.8x | 6.2x | 2.6x | |
Price / LTM Sales | 11.8x | 14.5x | 3.2x | |
Upside (Analyst Target) | - | 5.3% | 46.0% | |
Fair Value Upside | Unlock | −18.9% | 6.3% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 0.00
Earnings
Latest Release
Apr 24, 2025
EPS / Forecast
-0.02 / --
Revenue / Forecast
87.00M / --
FAQ
What Is the Chengdu Olymvax Biopharmaceuticals (688319) Stock Price Today?
The Chengdu Olymvax Biopharmaceuticals stock price today is 17.75.
What Stock Exchange Does Chengdu Olymvax Biopharmaceuticals Trade On?
Chengdu Olymvax Biopharmaceuticals is listed and trades on the Shanghai Stock Exchange stock exchange.
What Is the Stock Symbol for Chengdu Olymvax Biopharmaceuticals?
The stock symbol for Chengdu Olymvax Biopharmaceuticals is "688319."
What Is the Chengdu Olymvax Biopharmaceuticals Market Cap?
As of today, Chengdu Olymvax Biopharmaceuticals market cap is 7.10B.
What Is Chengdu Olymvax Biopharmaceuticals's Earnings Per Share (TTM)?
The Chengdu Olymvax Biopharmaceuticals EPS (TTM) is 0.10.
When Is the Next Chengdu Olymvax Biopharmaceuticals Earnings Date?
Chengdu Olymvax Biopharmaceuticals will release its next earnings report on 28 Aug 2025.
From a Technical Analysis Perspective, Is 688319 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Chengdu Olymvax Biopharmaceuticals Stock Split?
Chengdu Olymvax Biopharmaceuticals has split 0 times.
How Many Employees Does Chengdu Olymvax Biopharmaceuticals Have?
Chengdu Olymvax Biopharmaceuticals has 470 employees.
What is the current trading status of Chengdu Olymvax Biopharmaceuticals (688319)?
As of 15 Jul 2025, Chengdu Olymvax Biopharmaceuticals (688319) is trading at a price of 17.75, with a previous close of 17.50. The stock has fluctuated within a day range of 17.51 to 17.85, while its 52-week range spans from 8.11 to 18.74.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.